These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27539170)

  • 1. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    Bansilal S; Castellano JM; Garrido E; Wei HG; Freeman A; Spettell C; Garcia-Alonso F; Lizano I; Arnold RJ; Rajda J; Steinberg G; Fuster V
    J Am Coll Cardiol; 2016 Aug; 68(8):789-801. PubMed ID: 27539170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
    Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
    Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
    Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
    Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study.
    Shalaeva EV; Bano A; Kasimov U; Janabaev B; Laimer M; Saner H
    Glob Heart; 2023; 18(1):61. PubMed ID: 37928361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polypill strategy to improve adherence: results from the FOCUS project.
    Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.
    Di Martino M; Kirchmayer U; Agabiti N; Bauleo L; Fusco D; Perucci CA; Davoli M
    BMJ Open; 2015 Jun; 5(6):e007866. PubMed ID: 26063569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full coverage for preventive medications after myocardial infarction.
    Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH;
    N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of pre- and posthospital medication adherence in myocardial infarction patients.
    Doll JA; Hellkamp AS; Thomas L; Fonarow GC; Peterson E; Wang TY
    Am Heart J; 2019 Feb; 208():74-80. PubMed ID: 30580129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
    Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
    JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.
    Adamek KE; Ramadurai D; Gunzburger E; Plomondon ME; Ho PM; Raghavan S
    J Am Heart Assoc; 2019 Feb; 8(3):e011448. PubMed ID: 30712488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of patients with coronary artery spasm who initially presented with acute myocardial infarction.
    Kim JB; Choi BG; Rha SW; Seo HS; Choi SY; Byun JK; Na JO; Choi CU; Kim EJ; Park CG; Oh DJ
    Coron Artery Dis; 2018 Jan; 29(1):60-67. PubMed ID: 29176378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.
    Kuepper-Nybelen J; Hellmich M; Abbas S; Ihle P; Griebenow R; Schubert I
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1451-60. PubMed ID: 22476389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction.
    Doll JA; Hellkamp AS; Goyal A; Sutton NR; Peterson ED; Wang TY
    JAMA Cardiol; 2016 Oct; 1(7):787-794. PubMed ID: 27541822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.
    Kronish IM; Ross JS; Zhao H; Muntner P
    Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):364-71. PubMed ID: 27220368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Adherence and Long-Term Outcomes in Non-Revascularized Patients Following Acute Myocardial Infarction.
    Khan R; Kaul P; Islam S; Savu A; Bagai A; van Diepen S; Bainey KR; Welsh RC; Goodman SG
    Am J Cardiol; 2021 Aug; 152():49-56. PubMed ID: 34120704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
    Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.